15-78494068-A-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004136.4(IREB2):​c.2472+12A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.995 in 1,613,748 control chromosomes in the GnomAD database, including 798,977 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.97 ( 72065 hom., cov: 32)
Exomes 𝑓: 1.0 ( 726912 hom. )

Consequence

IREB2
NM_004136.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.00800

Publications

9 publications found
Variant links:
Genes affected
IREB2 (HGNC:6115): (iron responsive element binding protein 2) The protein encoded by this gene is an RNA-binding protein that acts to regulate iron levels in the cells by regulating the translation and stability of mRNAs that affect iron homeostasis under conditions when iron is depleted. When iron levels are low, this protein binds to iron-responsive elements (IRES), stem-loop structures located either in the 5' or 3' UTRs. Binding to the 5' UTR represses translation, while binding to the 3' UTR inhibits mRNA degradation. When iron is found in the cell, this protein is degraded in a F-box and leucine rich repeat protein 5-dependent manner. Variants in this gene have been associated with lung cancer and chronic obstructive pulmonary disease (COPD). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Aug 2017]
IREB2 Gene-Disease associations (from GenCC):
  • neurodegeneration, early-onset, with choreoathetoid movements and microcytic anemia
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 15-78494068-A-C is Benign according to our data. Variant chr15-78494068-A-C is described in ClinVar as Benign. ClinVar VariationId is 1300042.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.993 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IREB2NM_004136.4 linkc.2472+12A>C intron_variant Intron 19 of 21 ENST00000258886.13 NP_004127.2 P48200-1D3DW85
IREB2NM_001320942.2 linkc.2301+12A>C intron_variant Intron 19 of 21 NP_001307871.2
IREB2NM_001354994.2 linkc.2301+12A>C intron_variant Intron 19 of 21 NP_001341923.2
IREB2NM_001320941.2 linkc.1722+12A>C intron_variant Intron 18 of 20 NP_001307870.2 P48200

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IREB2ENST00000258886.13 linkc.2472+12A>C intron_variant Intron 19 of 21 1 NM_004136.4 ENSP00000258886.8 P48200-1
IREB2ENST00000558570.5 linkn.*1739+12A>C intron_variant Intron 18 of 20 1 ENSP00000454063.1 H0YNL8
IREB2ENST00000559091.1 linkc.-143A>C upstream_gene_variant 3 ENSP00000453863.1 H0YN46

Frequencies

GnomAD3 genomes
AF:
0.972
AC:
147871
AN:
152156
Hom.:
72013
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.901
Gnomad AMI
AF:
1.00
Gnomad AMR
AF:
0.992
Gnomad ASJ
AF:
1.00
Gnomad EAS
AF:
1.00
Gnomad SAS
AF:
1.00
Gnomad FIN
AF:
1.00
Gnomad MID
AF:
0.997
Gnomad NFE
AF:
1.00
Gnomad OTH
AF:
0.982
GnomAD2 exomes
AF:
0.993
AC:
248393
AN:
250114
AF XY:
0.995
show subpopulations
Gnomad AFR exome
AF:
0.901
Gnomad AMR exome
AF:
0.996
Gnomad ASJ exome
AF:
1.00
Gnomad EAS exome
AF:
1.00
Gnomad FIN exome
AF:
1.00
Gnomad NFE exome
AF:
1.00
Gnomad OTH exome
AF:
0.998
GnomAD4 exome
AF:
0.997
AC:
1457464
AN:
1461474
Hom.:
726912
Cov.:
46
AF XY:
0.998
AC XY:
725311
AN XY:
727036
show subpopulations
African (AFR)
AF:
0.903
AC:
30182
AN:
33440
American (AMR)
AF:
0.995
AC:
44427
AN:
44628
Ashkenazi Jewish (ASJ)
AF:
1.00
AC:
26105
AN:
26106
East Asian (EAS)
AF:
1.00
AC:
39678
AN:
39678
South Asian (SAS)
AF:
1.00
AC:
86204
AN:
86214
European-Finnish (FIN)
AF:
1.00
AC:
53414
AN:
53414
Middle Eastern (MID)
AF:
0.995
AC:
5738
AN:
5768
European-Non Finnish (NFE)
AF:
1.00
AC:
1111721
AN:
1111852
Other (OTH)
AF:
0.994
AC:
59995
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
190
380
569
759
949
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21668
43336
65004
86672
108340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.972
AC:
147983
AN:
152274
Hom.:
72065
Cov.:
32
AF XY:
0.974
AC XY:
72488
AN XY:
74444
show subpopulations
African (AFR)
AF:
0.901
AC:
37393
AN:
41510
American (AMR)
AF:
0.992
AC:
15182
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
1.00
AC:
3470
AN:
3470
East Asian (EAS)
AF:
1.00
AC:
5188
AN:
5188
South Asian (SAS)
AF:
1.00
AC:
4826
AN:
4826
European-Finnish (FIN)
AF:
1.00
AC:
10616
AN:
10616
Middle Eastern (MID)
AF:
1.00
AC:
294
AN:
294
European-Non Finnish (NFE)
AF:
1.00
AC:
68024
AN:
68038
Other (OTH)
AF:
0.982
AC:
2078
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
199
398
597
796
995
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
914
1828
2742
3656
4570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.992
Hom.:
93985
Bravo
AF:
0.968
Asia WGS
AF:
0.994
AC:
3455
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Neurodegeneration, early-onset, with choreoathetoid movements and microcytic anemia Benign:1
Aug 19, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.88
DANN
Benign
0.57
PhyloP100
-0.0080
PromoterAI
-0.00020
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4887060; hg19: chr15-78786410; API